Dei BioPharma Ltd is a biotech and pharmaceutical research firm duly incorporated in Uganda, specializing in the development and manufacture of innovative medicines and vaccines.
The development of our iconic drugs and vaccines manufacturing facility situated at Mattuga, Wakiso District, near Kampala in Uganda, was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President).
The state-of-the-art facility, valued at USD 1.1 billion shall produce high-quality medicines across a wide range of therapeutic areas. These include malaria, cancer, generics, beta-lactums, non betalactums, nutraceuticals, parentals, Heparin, APIs, Insulin, Glagine, vaccines and monocolonal antibodies.
The manufacturing facility is gearing to produce one billion doses of mRNA vaccines guided by the most stringent global GMP including the US FDA, EU (EMA) and the World Health Organization (WHO) standards.
Dei Biopharma Ltd is currently valued at USD 2.5 billion.